These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 24605816)

  • 1. Enhanced in vitro CA1 network activity in a sodium channel β1(C121W) subunit model of genetic epilepsy.
    Hatch RJ; Reid CA; Petrou S
    Epilepsia; 2014 Apr; 55(4):601-8. PubMed ID: 24605816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sodium channel β1 subunit localizes to axon initial segments of excitatory and inhibitory neurons and shows regional heterogeneity in mouse brain.
    Wimmer VC; Harty RC; Richards KL; Phillips AM; Miyazaki H; Nukina N; Petrou S
    J Comp Neurol; 2015 Apr; 523(5):814-30. PubMed ID: 25421039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β1-C121W Is Down But Not Out: Epilepsy-Associated Scn1b-C121W Results in a Deleterious Gain-of-Function.
    Kruger LC; O'Malley HA; Hull JM; Kleeman A; Patino GA; Isom LL
    J Neurosci; 2016 Jun; 36(23):6213-24. PubMed ID: 27277800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network-specific mechanisms may explain the paradoxical effects of carbamazepine and phenytoin.
    Thomas EA; Petrou S
    Epilepsia; 2013 Jul; 54(7):1195-202. PubMed ID: 23566163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of XE991, retigabine, losigamone and ZD7288 on kainate-induced theta-like and gamma network oscillations in the rat hippocampus in vitro.
    Boehlen A; Kunert A; Heinemann U
    Brain Res; 2009 Oct; 1295():44-58. PubMed ID: 19699191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy.
    Gunthorpe MJ; Large CH; Sankar R
    Epilepsia; 2012 Mar; 53(3):412-24. PubMed ID: 22220513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A thermoprotective role of the sodium channel β1 subunit is lost with the β1 (C121W) mutation.
    Egri C; Vilin YY; Ruben PC
    Epilepsia; 2012 Mar; 53(3):494-505. PubMed ID: 22292491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenytoin- and carbamazepine-resistant spontaneous bursting in rat entorhinal cortex is blocked by retigabine in vitro.
    Smith MD; Adams AC; Saunders GW; White HS; Wilcox KS
    Epilepsy Res; 2007 May; 74(2-3):97-106. PubMed ID: 17395429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of eslicarbazepine on persistent Na⁺ current and the role of the Na⁺ channel β subunits.
    Doeser A; Soares-da-Silva P; Beck H; Uebachs M
    Epilepsy Res; 2014 Feb; 108(2):202-11. PubMed ID: 24368131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KCNQ3 is the principal target of retigabine in CA1 and subicular excitatory neurons.
    Varghese N; Lauritano A; Taglialatela M; Tzingounis AV
    J Neurophysiol; 2021 Apr; 125(4):1440-1449. PubMed ID: 33729829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential gene expression profiles of two excitable rat cell lines after over-expression of WT- and C121W-β1 sodium channel subunits.
    Baroni D; Moran O
    Neuroscience; 2015 Jun; 297():105-17. PubMed ID: 25827112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of β1 accessory Na+ channel subunits causes failure of carbamazepine, but not of lacosamide, in blocking high-frequency firing via differential effects on persistent Na+ currents.
    Uebachs M; Albus C; Opitz T; Isom L; Niespodziany I; Wolff C; Beck H
    Epilepsia; 2012 Nov; 53(11):1959-67. PubMed ID: 23016711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The spectrum of anticonvulsant efficacy of retigabine (ezogabine) in animal models: implications for clinical use.
    Large CH; Sokal DM; Nehlig A; Gunthorpe MJ; Sankar R; Crean CS; Vanlandingham KE; White HS
    Epilepsia; 2012 Mar; 53(3):425-36. PubMed ID: 22221318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mice carrying the szt1 mutation exhibit increased seizure susceptibility and altered sensitivity to compounds acting at the m-channel.
    Otto JF; Yang Y; Frankel WN; Wilcox KS; White HS
    Epilepsia; 2004 Sep; 45(9):1009-16. PubMed ID: 15329063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thermosensitive mutation alters the effects of lacosamide on slow inactivation in neuronal voltage-gated sodium channels, NaV1.2.
    Abdelsayed M; Sokolov S; Ruben PC
    Front Pharmacol; 2013; 4():121. PubMed ID: 24065921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potent KCNQ2/3-specific channel activator suppresses in vivo epileptic activity and prevents the development of tinnitus.
    Kalappa BI; Soh H; Duignan KM; Furuya T; Edwards S; Tzingounis AV; Tzounopoulos T
    J Neurosci; 2015 Jun; 35(23):8829-42. PubMed ID: 26063916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Excitotoxic-mediated transcriptional decreases in HCN2 channel function increase network excitability in CA1.
    Adams BE; Reid CA; Myers D; Ng C; Powell K; Phillips AM; Zheng T; O'Brien TJ; Williams DA
    Exp Neurol; 2009 Sep; 219(1):249-57. PubMed ID: 19500574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus.
    Wimmer VC; Reid CA; Mitchell S; Richards KL; Scaf BB; Leaw BT; Hill EL; Royeck M; Horstmann MT; Cromer BA; Davies PJ; Xu R; Lerche H; Berkovic SF; Beck H; Petrou S
    J Clin Invest; 2010 Aug; 120(8):2661-71. PubMed ID: 20628201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel dual-mechanism Kv7 potassium channel/TSPO receptor activator GRT-X is more effective than the Kv7 channel opener retigabine in the 6-Hz refractory seizure mouse model.
    Bloms-Funke P; Bankstahl M; Bankstahl J; Kneip C; Schröder W; Löscher W
    Neuropharmacology; 2022 Feb; 203():108884. PubMed ID: 34785163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced dendritic arborization and hyperexcitability of pyramidal neurons in a Scn1b-based model of Dravet syndrome.
    Reid CA; Leaw B; Richards KL; Richardson R; Wimmer V; Yu C; Hill-Yardin EL; Lerche H; Scheffer IE; Berkovic SF; Petrou S
    Brain; 2014 Jun; 137(Pt 6):1701-15. PubMed ID: 24747835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.